MedPath

Study of Sitagliptin Treatment for Glycemic Control and Prevention of GAD-Ab Positive Non-insulin Dependent Diabetes Mellitus in Osaka

Not Applicable
Recruiting
Conditions
GAD-Ab positive non-insulin dependent diabetes mellitus
Registration Number
JPRN-UMIN000007926
Lead Sponsor
STGP-OSAKA study group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1. Injection of insulin within 3 month before entry point 2. Pregnant or planning to be pregnant 3. Diabetic nephropathy: Class 3 or higher 4. Diabetic retinopathy: Preproliferative or higher 5. NYHA 3-4 6. History in use of DPP-4 inhibitor or GLP-1 analogue. 7. Physician's judgment.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath